After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
MREO belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Mereo Biopharma Group Plc ADR is $481.21M. A total of 0.92 million shares were traded on the day, compared to an average of 1.06M shares.
In the most recent transaction, Scots-Knight Denise sold 60,046 shares of MREO for 4.22 per share on Sep 13 ’24. After the transaction, the Chief Executive Officer now owns 808,921 company shares. In a previous transaction on Sep 12 ’24, Scots-Knight Denise sold 28,611 shares at 4.47 per share. MREO shares that Chief Executive Officer owns now total 868,967.
Among the insiders who sold shares, Lewicki John A. disposed of 10,937 shares on Sep 13 ’24 at a per-share price of $4.22. This resulted in the Chief Scientific Officer holding 78,630 shares of MREO after the transaction. In another insider transaction, Lewicki John A. sold 5,212 shares at $4.47 per share on Sep 12 ’24. Company shares held by the Chief Scientific Officer now total 89,567.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, MREO has a high of $5.02 and a low of $2.53.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. MREO’s latest balance sheet shows that the firm has $127.27M in Cash & Short Term Investments as of fiscal 2021. There were $22.62M in debt and $16.93M in liabilities at the time. Its Book Value Per Share was $0.47, while its Total Shareholder’s Equity was $118.77M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MREO is Buy with a score of 4.86.
